Published in Obesity and Diabetes Week, May 3rd, 2004
Studies conducted by Interleukin Genetics have demonstrated certain variations (single nucleotide polymorphisms) in the IL-1 genes produce lifelong tendencies to have more inflammation or qualitative differences in inflammation mechanisms.
The new patent is based on the discovery that individuals with diabetes who have certain common variations in the IL-1 genes have an increased risk for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week